AI-ACCELERATED DRUG DISCOVERY

Optimizing Lipid-Based Drug Formulations

Enabling clinical transition through enhanced drug loading and stability in nanoparticle formulations

AI revolutionizes the drug discovery process

Background

Two IND-stage drug candidates, act simultaneously as agonists of toll-like receptors TLR4 and TLR7. The compounds are intended to be delivered in liposomes or lipidic nanoparticles, but the drug load was insufficient. The goal was to perform the computational search for optimal lipid composition for both formulations, which maximizes the drug load in liposomes and ensures structural integrity and optimal size of nanoparticles for different molar ratios of the drugs.

Methodology

  • 24 different lipid compositions were tested computationally using a combination of Molecular Dynamics techniques such as:
    • Spontaneous incorporation into the bilayers.
    • Alchemical free energy simulations of incorporation.
    • Self-assembly of drug-lipid mixtures.
    • Umbrella sampling simulation of drug incorporation.
  • Self-assembly of nanoparticles formed by pristine drugs and their mixtures was simulated under different conditions.
Self-assembled bilayer with incorporated drugs.
Potentials of mean force for drug incorporation into the bilayer.

Results

Results for liposome formulation:  
Computational screening of 24 lipid compositions allowed us to select 3 compositions, which maximize the free energy of drug incorporation into the lipid membrane and thus should have the best drug load. Experimental validation confirmed these findings with the increase of drug load up to 20 times in comparison to the initial lipid composition.

Results for nanoparticle formulation:  
It was shown that the stable nanoparticles of desirable sizes are formed by compound #1 or by the mixture of both compounds with a molar ratio up to 1:1. Higher ratios lead to the formation of undesirable amorphous aggregates. These results are currently used in the experimental optimization of nanoparticle formulation.

The potentials of mean force for drug incorporation into the bilayers of different compositions. The lower the minimum the better.
Simulation snapshots (left) and the particle surface reconstructions (right) of the nanoparticles with different molar ratios of two studied compounds.